Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan-Reference-Cited by-同舟云学术

Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan

Published:2020-10-25 Issue:2 Volume:48 Page:175-183
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J. Dermatol.

Author:

Fujita Hideki¹^ORCID,Ohtsuki Mamitaro²,Morita Akimichi³^ORCID,Nagao Ryuji⁴,Seko Noriko⁴,Matsumoto Kazuko⁴^ORCID,Tani Yumiko⁴^ORCID,Terui Tadashi¹^ORCID

Affiliation:

1. Division of Cutaneous Science Department of Dermatology Nihon University School of Medicine TokyoJapan

2. Jichi Medical University ShimotsukeJapan

3. Department of Geriatric and Environmental Dermatology Nagoya City University Graduate School of Medical Sciences NagoyaJapan

4. Novartis Pharma K.K. Tokyo Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15655

Reference35 articles.

1. Psoriasis

2. A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

3. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production

4. Psoriasis: epidemiology, clinical features, and quality of life

5. Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience;Journal of Personalized Medicine;2024-07-03

2. Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review;Journal of Cutaneous Medicine and Surgery;2024-06-07

3. Effectiveness of biologic treatment for psoriasis in Malaysia: Real-world evidence and review of current evidence from Southeast Asia;Dermatologica Sinica;2024-04

4. Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea;Therapeutic Advances in Chronic Disease;2024-01

5. Predictors for the effectiveness of 75 mg risankizumab in treating psoriasis—A real‐word evidence from a 52‐week retrospective study;Experimental Dermatology;2023-10-21